These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18199361)

  • 1. Re: Interleukin-11 attenuates ifosfamide-induced hemorrhagic cystitis.
    Gorczynska E
    Int Braz J Urol; 2007; 33(6):850-1. PubMed ID: 18199361
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Interleukin-11 attenuates ifosfamide-induced hemorrhagic cystitis.
    Raj A; Cheerva AC; Bertolone SJ
    Int Braz J Urol; 2007; 33(6):852-3. PubMed ID: 18199362
    [No Abstract]   [Full Text] [Related]  

  • 3. Interleukin-11 attenuates ifosfamide-induced hemorrhagic cystitis.
    Mota JM; Brito GA; Loiola RT; Cunha FQ; Ribeiro Rde A
    Int Braz J Urol; 2007; 33(5):704-10. PubMed ID: 17980069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous subcutaneous administration of mesna to prevent ifosfamide-induced hemorrhagic cystitis.
    Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):97-8. PubMed ID: 8677458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder urotoxicity pathophysiology induced by the oxazaphosphorine alkylating agents and its chemoprevention .
    Dobrek Ł; Thor PJ
    Postepy Hig Med Dosw (Online); 2012 Sep; 66():592-602. PubMed ID: 23001201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparision of uroprotective activity of reduced glutathione with mesna in ifosfamide induced hemorrhagic cystitis in rats.
    Ali SA; Danda SK; Basha SA; Rasheed A; Ahmed O; Ahmed MM
    Indian J Pharmacol; 2014; 46(1):105-8. PubMed ID: 24550594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral administration of mesna with ifosfamide.
    Goren MP
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):91-6. PubMed ID: 8677457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophils contribute to the pathogenesis of hemorrhagic cystitis induced by ifosfamide.
    Dornelas-Filho AF; Pereira VBM; Wong DVT; Nobre LMS; Melo AT; Silva CMS; Wanderley CWS; Nour ML; Araújo LCNC; Silva RO; Pinto FMM; Bingana RD; Souza MHLP; Alencar NMN; Silva PGB; Alves APNN; Almeida PRC; Cunha FQ; Lima-Júnior RCP
    Int Immunopharmacol; 2018 Sep; 62():96-108. PubMed ID: 29990699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of Advances in Uroprotective Agents for Cyclophosphamide- and Ifosfamide-induced Hemorrhagic Cystitis.
    Matz EL; Hsieh MH
    Urology; 2017 Feb; 100():16-19. PubMed ID: 27566144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ifosfamide-induced hemorrhagic cystitis and its prevention by mesna].
    Matsumoto S; Kawaguchi N; Manabe J; Kuroda H; Shimoji T
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):965-8. PubMed ID: 7794006
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined intravenous and oral mesna in outpatients treated with ifosfamide.
    Goren MP; McKenna LM; Goodman TL
    Cancer Chemother Pharmacol; 1997; 40(5):371-5. PubMed ID: 9272112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of ketamine against hemorrhagic cystitis in rats receiving ifosfamide.
    Ozguven AA; Yılmaz O; Taneli F; Ulman C; Vatansever S; Onag A
    Indian J Pharmacol; 2014; 46(2):147-51. PubMed ID: 24741183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Side effects of ifosfamide.
    Klastersky J
    Oncology; 2003; 65 Suppl 2():7-10. PubMed ID: 14586140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target Inhibition of IL-1 Receptor Prevents Ifosfamide Induced Hemorrhagic Cystitis in Mice.
    Leite CA; Alencar VT; Melo DL; Mota JM; Melo PH; Mourão LT; Wong DV; Magalhães PJ; Santos AA; Brito GA; Lima-Júnior RC; Cunha FQ; Ribeiro RA
    J Urol; 2015 Dec; 194(6):1777-86. PubMed ID: 26220217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amifostine and glutathione prevent ifosfamide- and acrolein-induced hemorrhagic cystitis.
    Batista CK; Mota JM; Souza ML; Leitão BT; Souza MH; Brito GA; Cunha FQ; Ribeiro RA
    Cancer Chemother Pharmacol; 2007 Jan; 59(1):71-7. PubMed ID: 16708234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of ifosfamide-induced hemorrhagic cystitis by continuous bladder irrigation.
    Fujita J; Matsumoto K; Kakizoe T; Murase T
    Urology; 1981 Sep; 18(3):250-1. PubMed ID: 7281389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Phellandrene attenuates tissular damage, oxidative stress, and TNF-α levels on acute model ifosfamide-induced hemorrhagic cystitis in mice.
    Gonçalves RLG; Cunha FVM; Sousa-Neto BPS; Oliveira LSA; Lopes ME; Rezende DC; Sousa IJO; Nogueira KM; Souza LKM; Medeiros JVR; Wong DVT; Pereira VMP; Lima-Júnior RCP; Sousa DP; Oliveira CPC; Almeida FRC; Oliveira FA
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Oct; 393(10):1835-1848. PubMed ID: 32415495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protective effect of 2-mercapto-ethane sulfonate (MESNA) on hemorrhagic cystitis induced by high-dose ifosfamide treatment tested by a randomized crossover trial.
    Sakurai M; Saijo N; Shinkai T; Eguchi K; Sasaki Y; Tamura T; Sano T; Suemasu K; Jett JR
    Jpn J Clin Oncol; 1986 Jun; 16(2):153-6. PubMed ID: 3090314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. U.S. Food and Drug Administration drug approval summaries: imatinib mesylate, mesna tablets, and zoledronic acid.
    Cohen MH; Dagher R; Griebel DJ; Ibrahim A; Martin A; Scher NS; Sokol GH; Williams GA; Pazdur R
    Oncologist; 2002; 7(5):393-400. PubMed ID: 12401901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uroprotective effect of pentoxifylline in cyclophosphamide-induced hemorrhagic cystitis in rats.
    Abo-Salem OM
    J Biochem Mol Toxicol; 2013 Jul; 27(7):343-50. PubMed ID: 23695977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.